Author | Mary J. Fidler, MD | OncLive

Author | Mary J. Fidler, MD

Articles

Dr. Fidler on the Utility of Dacomitinib in EGFR-Mutant NSCLC

December 16, 2019

Video

Mary J. Fidler, MD, discusses the utility of dacomitinib (Vizimpro) in patients with EGFR-mutant non–small cell lung cancer.

Dr. Fidler on the FLAURA Trial in EGFR-Mutant NSCLC

November 22, 2019

Video

Mary J. Fidler, MD, discusses overall survival data of the phase III FLAURA trial looking at frontline osimertinib in EGFR-mutant non–small cell lung cancer.

Dr. Fidler on RELAY Trial Results in EGFR+ NSCLC

November 14, 2019

Video

Mary J. Fidler, MD, discusses the results of the phase III RELAY trial in treatment-naïve patients with EGFR-mutant non–small cell lung cancer.

Dr. Fidler on Novel Chemotherapy Strategies in Nonsquamous NSCLC

June 18, 2019

Video

Mary J. Fidler, MD, associate professor, Rush University Medical Center, discusses progression-free survival (PFS) and overall survival (OS) in patients with stage IV, nonsquamous, non–small cell lung cancer patients (NSCLC) treated with first-line pemetrexed and platinum followed by pemetrexed maintenance.

x